Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML
Public ClinicalTrials.gov record NCT01883362. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized Trial of Standard of Care, With or Without Midostaruin to Prevent Relapse Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With FLT3-ITD Mutated Acute Myeloid Leukemia
Study identification
- NCT ID
- NCT01883362
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Interventions
- Midostaurin Drug
- Standard of Care Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 5, 2014
- Primary completion
- Apr 29, 2018
- Completion
- Apr 29, 2018
- Last update posted
- Mar 16, 2021
2014 – 2018
United States locations
- U.S. sites
- 18
- U.S. states
- 15
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California San Diego Moores Cancer Center | La Jolla | California | 92093-0987 | — |
| University of California at Los Angeles Oncology | Los Angeles | California | 90095 | — |
| SCRI- Colorado Blood Cancer Institute | Denver | Colorado | 80218 | — |
| H Lee Moffitt Cancer Center and Research Institute Oncology | Tampa | Florida | 33612 | — |
| Northside Hospital | Atlanta | Georgia | 30342 | — |
| University of Chicago Medical Center | Chicago | Illinois | 60637 | — |
| Karmanos Cancer Institute Karmanos - Wayne State | Detroit | Michigan | 48201 | — |
| Mayo Clinic - Rochester | Rochester | Minnesota | 55905 | — |
| Washington University School Of Medicine-Siteman Cancer Ctr Washington U School of Med | St Louis | Missouri | 63110 | — |
| Hackensack University Medical Center Hackensack Univ Med Ctr (32) | Hackensack | New Jersey | 07601 | — |
| University of North Carolina at Chapel Hill University of North Carolina 6 | Chapel Hill | North Carolina | 27599-9500 | — |
| University Hospitals Case Medical Center | Cleveland | Ohio | 44106 | — |
| Oregon Health Sciences University | Portland | Oregon | 97239 | — |
| Tennessee Oncology Sarah Cannon Research Inst. | Nashville | Tennessee | 37203 | — |
| Vanderbilt Univeristy Oncology | Nashville | Tennessee | 37232 | — |
| Baylor Health Care System/Sammons Cancer Center Oncology | Dallas | Texas | 75246 | — |
| Texas Transplant Physicians Group Oncology 2 | San Antonio | Texas | 78229 | — |
| Fred Hutchinson Cancer Research Center Oncology | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01883362, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 16, 2021 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01883362 live on ClinicalTrials.gov.